NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer
J. J. Li, A. Vasciaveo, D. Karagiannis…·M. M. Shen
This study identifies NSD2 as a key driver of lineage plasticity and castration-resistance in neuroendocrine prostate cancer, showing its inhibition can restore sensitivity to AR inhibitors.